patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · vaccine component
pneumococcal polysaccharide [21-valent] vaccine
pre_registrationupdated 2mo agoby $MRK Merck & Co., Inc.🔗 ChEMBL
community read0 votes
Vaccine component drug with a maximum clinical stage of Approval (across all indications), with an approval for pneumococcal infection and 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that